Neuroendocrine abnormalities associated with untreated first episode patients of major depressive disorder with comorbid obstructive sleep apnea

Haiyin Zhang,Jing Yuan,Yan Zhang,YuJun Wei,Li Xu,Fang Zhou,Xinxin Fan,ChuanYuan Kang,JianZhong Yang
DOI: https://doi.org/10.1016/j.psychres.2020.113248
IF: 11.3
2020-09-01
Psychiatry Research
Abstract:<p>There are few studies that explore the relationship of neuroendocrine hormones of the HPA, HPT and HPG axes with major depressive disorder (MDD) with comorbid obstructive sleep apnea (OSA). The aim of this study is to examine neuroendocrine abnormalities and the relationship in untreated first episode patients of MDD comorbided with OSA. Polysomnography, neuroendocrine hormones were determined for 111 patients. After excluding the influences of age and BMI, phase I in non-REM sleep (N1)% increased significantly in MDD with OSA when compared with non-OSA. In the OSA group, cortisol increased and exceeded the normal standard, and for the numbers of patients exceeding the normal range, there were significant difference between two groups. In MDD with OSA, adrenocorticotropic hormone was significantly negatively correlated with slow wave sleep (SWS)%, while thyroxine was significantly correlated with phase II in non-REM sleep (N2)%, and prolactin was significantly negatively correlated with N1%. This study revealed that for untreated first episode MDD patients with OSA, the HPA axis was hyperfunctional. Cortisol and adrenocorticotropic hormone may be increased along with disturbed sleep structure and less slow-wave sleep time. Concurrently prolactin was decreased and thyroxine increased during the N1 and N2 phase of sleep.</p>
psychiatry
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the neuroendocrine abnormalities in patients with untreated first - episode major depressive disorder (MDD) combined with obstructive sleep apnea (OSA) and their relationship with sleep disorders. Specifically, the study aims to: 1. **Examine the neuroendocrine abnormalities in untreated first - episode MDD patients combined with OSA**: In particular, the functional states of the hypothalamic - pituitary - adrenal axis (HPA), the hypothalamic - pituitary - thyroid axis (HPT), and the hypothalamic - pituitary - gonadal axis (HPG). 2. **Analyze the relationship between these neuroendocrine abnormalities and sleep architecture disorders**: Evaluate the sleep quality of patients by polysomnography (PSG) and explore the correlation between neuroendocrine hormone levels and sleep stages. ### Research Background - The incidence of obstructive sleep apnea (OSA) is relatively high in MDD patients, and their symptoms overlap, such as sleep disorders, fatigue, and cognitive decline. - OSA may exacerbate the severity of MDD symptoms and affect the efficacy of antidepressant drugs and patient compliance. - Previous studies have shown that OSA is related to the dysfunction of the neuroendocrine system (especially the HPA axis), but there are few studies on the specific neuroendocrine changes in MDD patients combined with OSA. ### Research Hypotheses - Sleep disorders are more severe and neuroendocrine abnormalities are more obvious in MDD patients combined with OSA. - There is a significant correlation between neuroendocrine abnormalities and sleep disorders, especially in untreated first - episode MDD patients. ### Main Findings - **Sleep architecture changes**: The light sleep stage (N1%) in MDD patients combined with OSA significantly increased, while slow - wave sleep (SWS%) decreased, indicating poor sleep quality and sleep architecture disorders. - **Neuroendocrine changes**: The cortisol (COR) level in the OSA group increased and exceeded the normal range, adrenocorticotropic hormone (ACTH) was significantly negatively correlated with the percentage of slow - wave sleep (SWS%), thyroxine (T4) was significantly positively correlated with non - rapid eye movement sleep stage 2 (N2%), and prolactin (PRL) was significantly negatively correlated with the light sleep stage (N1%). - **Overactive HPA axis**: The HPA axis in MDD patients combined with OSA is hyperfunctioning, manifested as increased cortisol and ACTH levels, which may further exacerbate depressive symptoms. Through these findings, the study reveals the complex relationship between the neuroendocrine system and sleep disorders in MDD patients combined with OSA, providing important clues for further understanding the pathological mechanisms of both.